Literature DB >> 29042000

Nociceptive blink reflex habituation biofeedback in migraine.

M de Tommaso, M Delussi.   

Abstract

Reduced habituation of the nociceptive blink reflex (NBR) is considered a trait marker for genetic predisposition to migraine. In this open-label randomized controlled study, we aimed to test the efficacy of a biofeedback training based on learning of habituation of the NBR (NBR biofeedback) compared with pharmacological (topiramate) treatment and NBR biofeedback plus topiramate treatment in a cohort of migraine without aura patients eligible for prophylaxis. Thirty-three migraine patients were randomly assigned to three months of treatment with: 1) NBR biofeedback, 2) NBR biofeedback plus topiramate 50 mg (b.i.d.), or 3) topiramate 50 mg (b.i.d.). Frequency of headache and disability changes were the main study outcomes. Anxiety, depression, sleep, fatigue, quality of life, allodynia and pericranial tenderness were also evaluated. NBR biofeedback reduced the R2 area, without improving R2 habituation. However, it reduced the frequency of headache and disability, similarly to the combined treatment and topiramate alone. Reduced habituation of the NBR is a stable neurophysiological pattern, scarcely modifiable by learning procedures. Training methods able to act on stress-related responses may modulate cortical mechanisms inducing migraine onset and trigeminal activation under stressful trigger factors.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29042000      PMCID: PMC5726347          DOI: 10.11138/fneur/2017.32.3.123

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  37 in total

Review 1.  Biofeedback in headache: an overview of approaches and evidence.

Authors:  Frank Andrasik
Journal:  Cleve Clin J Med       Date:  2010-07       Impact factor: 2.321

2.  Reduced habituation to experimental pain in migraine patients: a CO(2) laser evoked potential study.

Authors:  M Valeriani; M de Tommaso; D Restuccia; D Le Pera; M Guido; G D Iannetti; G Libro; A Truini; G Di Trapani; F Puca; P Tonali; G Cruccu
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

Review 3.  Habituation and migraine.

Authors:  Gianluca Coppola; Francesco Pierelli; Jean Schoenen
Journal:  Neurobiol Learn Mem       Date:  2008-08-26       Impact factor: 2.877

4.  A comparative study of cortical responses evoked by transcutaneous electrical vs CO(2) laser stimulation.

Authors:  Marina de Tommaso; Roberto Santostasi; Vito Devitofrancesco; Giovanni Franco; Eleonora Vecchio; Marianna Delussi; Paolo Livrea; Zaza Katzarava
Journal:  Clin Neurophysiol       Date:  2011-06-08       Impact factor: 3.708

5.  Can allodynic migraine patients be identified interictally using a questionnaire?

Authors:  Moshe Jakubowski; Stephen Silberstein; Avi Ashkenazi; Rami Burstein
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

6.  The mechanisms of antihyperalgesic effect of topiramate in a rat model of inflammatory hyperalgesia.

Authors:  Sonja Lj Paranos; Maja A Tomić; Ana M Micov; Radica M Stepanović-Petrović
Journal:  Fundam Clin Pharmacol       Date:  2011-12-05       Impact factor: 2.748

Review 7.  Central sensitization in tension-type headache--possible pathophysiological mechanisms.

Authors:  L Bendtsen
Journal:  Cephalalgia       Date:  2000-06       Impact factor: 6.292

8.  Fibromyalgia comorbidity in primary headaches.

Authors:  M de Tommaso; M Sardaro; C Serpino; F Costantini; E Vecchio; M Pia Prudenzano; P Lamberti; P Livrea
Journal:  Cephalalgia       Date:  2009-12-15       Impact factor: 6.292

9.  Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride.

Authors:  K A Holroyd; J L France; G E Cordingley; L A Rokicki; S A Kvaal; G L Lipchik; H R McCool
Journal:  J Consult Clin Psychol       Date:  1995-04

10.  Biofeedback treatment for headache disorders: a comprehensive efficacy review.

Authors:  Yvonne Nestoriuc; Alexandra Martin; Winfried Rief; Frank Andrasik
Journal:  Appl Psychophysiol Biofeedback       Date:  2008-08-26
View more
  2 in total

1.  Preventive treatment with CGRP monoclonal antibodies restores brain stem habituation deficits and excitability to painful stimuli in migraine: results from a prospective case-control study.

Authors:  Anne Thiele; Lara Klehr; Sebastian Strauß; Anselm Angermaier; Ulf Schminke; Martin Kronenbuerger; Steffen Naegel; Robert Fleischmann
Journal:  J Headache Pain       Date:  2021-12-11       Impact factor: 7.277

2.  Migraine Prevention through Ketogenic Diet: More than Body Mass Composition Changes.

Authors:  Mariarosaria Valente; Riccardo Garbo; Francesca Filippi; Alice Antonutti; Veronica Ceccarini; Yan Tereshko; Cherubino Di Lorenzo; Gian Luigi Gigli
Journal:  J Clin Med       Date:  2022-08-23       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.